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Fc receptors have been found on  many different cells including B  and T 
lymphocytes, macrophages, neutrophils, and K  cells, as well as cells not in- 
volved in the immune system. Some cellular functions such as phagocytosis of 
IgG-coated particles (1, 2) and the antibody-dependent cell-mediated cytotoxic- 
ity reaction (3) can clearly be attributed to this surface activity. On the other 
hand, the functional significance of Fc receptors on other cells such as B and T 
lymphocytes has not as yet been elucidated. As part of our investigations of the 
possible function of Fc receptors, we have studied the specificity of receptors for 
immunoglobulins of different IgG subclasses, as well as the degree of polymeri- 
zation of the immunoglobulin capable of binding to these receptors. For this 
purpose myeloma proteins of different IgG subclasses were chemically cross- 
linked by bis-diazotized benzidine (BDB).'  Monomer IgG and IgG aggregates of 
comparable size,  representative of the different subclasses, were examined for 
their capacity to bind to receptors on different established cell lines and normal 
cells.  Our findings indicate that the binding of myeloma proteins is dependent 
both upon subclass and degree of polymerization. Furthermore, studies on a 
macrophage-like cell line (P388) strongly suggest the presence of at least two 
different receptors for IgG on this cell, one characterized by its reactivity with 
monomeric IgG2a and  the  other for its  activity with  aggregated IgG  of all 
subclasses. 
Materials and Methods 
Myeloma Proteins.  The following IgG myeloma proteins were used in this study:  MOPC-21 
(IgG1), PC-5, and HOPC-1 (IgG2a), MOPC-141 (IgG2b), and J606 (IgGz). The myeloma proteins were 
isolated by starch block electrophoresis. Only the peak tubes of the myeloma protein-containing 
fractions were used. The myeloma proteins were cross-linked with BDB according to a modifica- 
tion  of the  method  of Ishizaka  (4)  resulting  in  soluble  complexes with  a  wide  range  of size. 
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1 Abbreviations used in this paper: BDB, bis-diazotized benzidine; BSS, balanced salt solution; 
BSS-BSA-NaN3, BSS plus 2.5 mg/ml bovine serum albumin and 0.1% sodium azide; FCS, fetal calf 
serum; SDS-PAGE, sodium dodecyl sulfate-pelyacrylamide gel electrophoresis. 
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Although several attempts were made, we were unable to produce soluble aggregates of the IgGs 
protein available to us (J606).  All BDB-treated proteins were dialyzed overnight against phos- 
phate-buffered saline (pH 7.0). Insoluble material was removed by centrifugation at 1,500 g for 15 
min. The soluble aggregates were subsequently fractionated on Sepharose 4B or Bio-gel A50m. 
Calculations of the molecular weight of the aggregates were based on their elution volumes from 
these columns. Aggregated and monomeric myeloma proteins were iodinated by the chloramine-T 
method (5). To prepare monomeric IgG, unaggregated protein was either centrifuged for 2.5 h at 
165,000 g  and the top one-half of the samples used, or it was filtered through a Sephadex G-200 
column and the descending portion of the IgG peak was used as the monomer preparation. 
Cells.  Cell lines were grown in spinner cultures in RPMI-1640 containing penicillin, strepto- 
mycin, and 10% heat-inactivated fetal calf serum (FCS). Peritoneal macrophages were obtained 
from  BDF1 mice  4  days after  injection of 1  ml  of 3%  thioglycolate broth.  Spleen  cells and 
thymocytes were obtained from 8- and 4-wk-old DBA/2 mice, respectively. Trypsinization was 
carried out by incubating 107 cells in 1 ml of balanced salt solution (BSS) with 0.1-1 mg trypsin 
(TPCK treated, Worthington Biochemical Corp., Freehold, N. J.) for 15-30 rain at 37°C. After 
being washed, cells were resuspended in BSS with 0.2 mg/ml soybean trypsin inhibiter. 
Spleen cells were fractionated into T-enriched CT") and B-enriched CB") populations by the 
nylon wool method (6). T and B cells were enumerated by determining the percentage of fluores- 
cent cells after staining with either fluoresceinated rabbit anti-mouse Ig (to detect B cells) or anti- 
Thy-1 and fluoresceinated rabbit anti-mouse Ig (to detect T  and B  cells). The T-cell fraction 
contained 68% Thy-l-positive  cells and 13% Ig-positive  cells; the B-cell fraction contained 13% Thy- 
1-positive cells and 52% Ig-pesitive cells. 
Assays for IgG Binding to Cells.  To 0.1 ml BSS-BSA-NaN3 in 5-ml polyethylene tubes was 
added 0.1 ml of inhibitor Ig or buffer and 0.1 ml of 125I-IgG (usually at a concentration of 0.01 mg/ 
ml). To this mixture, 3-10 × l0  s cells in 0.3 ml were added. Incubation with intermittent agitation 
proceeded for 60 min at 4°C for macrophage-like cells and at 37°C for all other cells (7). The amount 
of radiolabeled IgG bound by the cells was determined by layering 0.2 ml of the reaction mixture 
on top of 1 ml cold fetal calf serum (FCS) in 1.5 ml conical polyethylene tubes and separating 
unbound from cell-associated IgG by centrifuging the cells through the FCS at 350 g  for 8 min. 
Tubes were then frozen in a bath of dry ice and ethanol, and the bottoms of the tubes containing 
the cell pellets were cut off with a hot wire and assayed for radioactivity. In control experiments 
without cells it was shown that only 0.01% of ~2~I-IgG  was found in the pellet portion of the tubes. 
Cells were also analyzed for bound ~25I-IgG  by autoradiography as previously described (7). 
Results 
I.  Receptor Activity for IgG on Different Mouse Cells and Cell Lines. Sub- 
class  Specificity and Aggregate  Size Requirements.  The  binding  capacity of 
the IgG subclasses for different cell lines was tested using IgG myeloma proteins 
in  three  different  polymeric  forms:  monomers,  (IgG)l;  tetramers,  (IgG)4;  and 
high molecular weight aggregates,  (IgG)>lOO. The size of the latter preparations 
was  estimated  by their  elution  from  agarose  columns  and  by sodium  dodecyl 
sulfate-polyacrylamide  gel electrophoresis (SDS-PAGE)  (8).  Representative  re- 
sults of one  of three  such  experiments  using these  preparations  are shown  in 
Table I. IgG binding  was studied with the following cell lines: P388  and J774, 
which are macrophage-like  cell ines  (9,  10); P815,  a  mastocytoma;  D2N,  an Ia- 
positive Friend  leukemia  virus-induced cell line (11); and $49,  a  Thy-l-positive 
lymphoma.  If monomer  binding were analyzed for subclass specificity, (IgG2a)l 
was  preferentially  bound  by the  macrophage-like  cell lines and  by P815.  The 
lymphoid  cell lines,  D2N  and  $49,  did not  express detectable  (IgG2a)l binding 
capacity. 
The  extent  of membrane  binding  of aggregated  IgG varied  among  the  cell 
types analyzed.  The differences observed were dependent  on both the subclass 
and the degree of aggregation.  Polymerization to a  mean  size of four (range two 1318  SPECIFICITY  OF  RECEPTORS  FOR  IgG 
TABLE  I 
Binding of  IgG of  Different Subclasses and Different Degrees of  Aggregation 
to Mouse Cell Lines 
IgG preparation 
Percent of ~25I-IgG bound to different cell lines 
P388  J774  P815  D2N  $49 
(IgG~)~  0.4  0.9  0.6  0.1  0.2 
(IgG2a)~  4.5  6.9  2.6  0.2  0.3 
(IgG2b)~  0.4  1.0  0.7  0.2  0.5 
(IgG3)j  0.1  0.2  0.2  0.1  0.2 
(IgG~)4  41.3  52.1  32.1  5.8  12.6 
(IgG2a)4  41.7  55.8  29.8  2.0  3.7 
(IgG2b)4  20.5  36.3  19.5  1.9  3.7 
(IgG1)>,oo  54.1  62.6  22.7  15.0  32.9 
(IgG2b)>loo  57.2  58.8  51.5  17.3  31.0 
P388, J774, and P815 cells were incubated at 4°C to prevent pinocytosis. D2N and 
$49  cells  were  incubated  at  37°C (7). P815 cells  were  also  studied  at  37°C and 
essentially the same binding was obtained at this temperature as that given at 4°C. 
Nonspecific uptake of IgG was assayed by measuring the amount of radioactivity in 
the cell pellet when a large excess of unlabeled  IgG was added to the incubation 
mixture of 12sI-IgG and cells. This nonspecific uptake was 0.2% or less for (IgG)~ and 
was 1% or less for aggregated IgG. 
to seven) increased remarkably the capacity ofIgG1, IgG2a, and IgG2b proteins to 
bind to these cells compared with monomer IgG. This was most marked with the 
(IgG~)4 protein, which bound to the cell types studied as well as or better than 
(IgG2a)4  and better than  (IgG2b)4.  When  (IgG)>loo aggregates  were used there 
was little or no increase in the uptake of IgG1 protein, whereas IgG2b now bound 
as well as IgG1, and in one case better (P815). Although aggregates of the IgG2~ 
protein  of this  high  molecular  weight  were  not  available  for  study,  results 
obtained using 10  x  10  s dalton aggregates,  (IgG)65,  indicated that in a  highly 
aggregated state IgG2a was usually the weakest binding protein (see below). 
The capacity of cells to bind high molecular weight aggregates was further 
analyzed using aggregates with a  mol wt of approximately 10  ~ daltons,  (IgG)es. 
To  study  normal  populations  of cells  with  considerable  heterogeneity  of Fc 
receptor activity, we analyzed aggregate binding by autoradiography. Table II 
shows these results.  It is apparent from these data that normal macrophages 
and the cell lines studied in Table I  were capable of binding 10-100-fold more 
aggregated IgG than normal T cells, B cells, thymocytes, and the Thy-l-positive 
tumors,  EL4 and  L5178.  The cells  studied  demonstrated  three fairly distinct 
patterns of reactivity with aggregates of the IgG subclasses used.  Macrophages 
and macrophage-like cell lines bound the aggregates of the three subclasses to a 
similar extent. In contrast, the group represented by D2N, $49, and P815 bound 
the IgGs~ protein less efficiently than either IgGsb or IgG1. The third group of 
cells which included normal T  cells, B cells, and thymocytes, together with the 
EL-4 and L5178 cell lines, bound IgG1 two to fourfold more efficiently than either 
IgG2a or IgG2b aggregates. 
II.  CharacteriZation of the Specificity of Monomer and Aggregated IgG Bind- 
ing by P388 Cells.  As shown in Table I, the macrophage-like cell lines (and to C.  H.  HEUSSER,  C.  L.  ANDERSON,  AND  H.  M.  GREY 
TABLE  II 
Binding of 125I-(IgV)e5 of Different Subclasses to Mouse Cell Lines and 
Normal Cells 
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Cell type 
Binding of 125I-aggregated myeloma proteins 
MOPC-21 IgGl  PC-5 IgG2a  MOPC-141 IgG2b 
grains~ell per day 
J774  74  102  101 
P388  103  118  ND 
Macrophages  100  96  130 
P815  89  48  89 
D2N  101  40  93 
$49  83  33  78 
EL4  9  2  4 
L5178  1.2  0.4  0.5 
Splenic T  7.2  1.8  2.8 
Splenic B  8.2  2.5  3.5 
Thymus  3.1  1.4  1.6 
Macrophages and macrophage-like cell lines (J774 and P388) were incubated at 
4°C, all other cell types at 37°C.  Autoradiographic preparations of these cells 
were exposed for different lengths of time and the grain distribution per cell 
was normalized for 1 day exposure. One of two similar experiments is shown. 
ND, not done. 
a lesser extent, P815) differed from the other cell types studied in that they were 
capable of binding significant quantities of (IgG2a)l. The preferential binding of 
monomer IgG2a contrasted with the equal binding capacity of all three sub- 
classes when aggregates were tested. These differences  suggested the possibility 
that two distinct receptors for IgG were present, one capable of binding (IgG2~)l 
preferentially to  other  monomer proteins,  and  one  capable  of binding only 
aggregated IgG  and  exhibiting  no  subclass  specificity.  In  order  to  further 
explore this possibility, the specificity of (IgG2~)l and aggregated IgG binding 
was investigated by determining the patterns of inhibition obtained with unla- 
beled monomeric and aggregated proteins of the different subclasses. 
(a)  INHIBITION  OF  BINDING  OF  AGGREGATED IgG TO  P388  CELLS.  The capacity 
of a 600-fold excess of unlabeled aggregates of the three subclasses to inhibit the 
binding of radiolabeled aggregates to P388 was determined. Inhibition of (IgG)4 
binding by unlabeled aggregates was high, varying from 73-99%, and no strik- 
ing degree of selectivity for the aggregates of any one particular subclass was 
revealed by this analysis.  In this experiment, however, since a  single large 
excess of unlabeled aggregated protein was used, the inhibition by aggregates 
was studied in a more quantitative way by comparing inhibitory capacities over 
a  wide range of inhibitor concentrations. These data are presented in Fig.  1. 
Tetramers of IgG1 and IgG2a inhibited the uptake of radiolabeled IgG2~ in a 
quantitatively similar fashion.  50%  inhibition was obtained with  13.5 ~g of 
IgG2~ and 17.5 ~g of IgG1. In experiments not shown, when inhibition of IgG1 
aggregate binding was studied, both IgG2a and IgG~ inhibited well (50% inhibi- 
tion being obtained with 21.5 and 12.5 ~g, respectively). In both experiments the 
tendency was noted for the homologous aggregates to inhibit somewhat more 1320  SPECIFICITY  OF  RECEPTORS  FOR  IgG 
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FIG. I.  Inhibition  of  aggregate  binding  by  aggregates. Binding  by  P388  cells  of  ~251-(IgG2a)4 
was inhibited  by varying amounts of  (IgG2a)4  (0--0) and (IgG1h (D--I:]).  Similar inhibition 
was noted. 
efficiently than heterologous aggregates. From these studies it was concluded 
that  IgG  aggregates of the different subclasses  could effectively inhibit  the 
binding of the other subclasses and therefore most likely bound to the same 
receptor structure on the cell surface. 
Next,  inhibition  of aggregate binding by monomeric proteins was studied. 
Using a  600-fold  excess of inhibitor,  the percentage inhibition obtained with 
monomers was as follows:  (IgG2b)l, 61-84%;  (IgG1)l,  42-51%;  (IgG2a)l,  16-42%; 
(IgG3),  12-19%.  Further, dose-response experiments using (IgG)l obtained by 
Sephadex gel filtration were performed. (IgG2a)l and (IgG2b)~ were compared for 
their capacity to  inhibit  the binding  of both  IgG~  or IgG2a aggregates.  30% 
inhibition of aggregate binding was obtained with 60  ~g of (IgG2b), whereas 
122-400 ~g of (IgG2a)l were needed for the same degree of inhibition. Thus, these 
data indicate that (IgG2b)l was the best inhibiter of (IgG)4 binding. 
The results described above suggest that the receptor capable of binding IgG 
aggregates, although not demonstrating subclass specificity when aggregates 
were used for inhibition studies, did express some degree of specificity for IgG2b 
when monomeric proteins were studied for inhibition. 
(b)  INHIBITION OF BINDING OF MONOMERIC IgG2a TO P388 CELLS.  The inhibi- 
tion of binding of radiolaboled (IgG2a)~ to P388 cells by other monomeric proteins 
is shown in Table III. The two IgG2~ proteins tested were efficient inhibitors of 
(IgG2a)~ binding,  whereas  the  IgG~,  IgG2b, and  IgG3  proteins  demonstrated 
negligible.inhibitory capacity. 
To study the quantitative aspects of this inhibition, we compared in a dose- 
response experiment the inhibitory capacity of G-200 fractionated (IgG2a)~ and 
(IgGsb)l.  These data are shown in Fig.  2.  (IgG2~)~ was a  much more efficient 
inhibitor than (IgG2b)~ achieving 40% inhibition with 4 ~g protein, whereas 150 
~g of (IgG2b)~ were needed to  achieve the same degree of inhibition.  These 
observations of (IgG)l inhibition of monomer IgG2a binding contrast with the 
data of inhibition of aggregate binding described in section IIa in that strong C.  H.  HEUSSER,  C.  L.  ANDERSON,  AND  H.  M.  GREY 
TABLE  III 
Inhibition of Radiolabeled (IgG2a) l Binding to P388 Cells by 
Unlabeled (IgG) 
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Inhibitor protein 
Percent inhibition of  ~2sI-(IgG2~)1  binding 
Exp. 1  Exp. 2 
(IgG1)~  22  5 
(IgGsa),  (PC-5)  80  57 
(IgG2a)l  (HOPC-1)  ND  46 
(]gG2b)l  20  5 
(IgGs)l  0  ND 
40-fold  weight excess of  unlabeled to labeled protein was added in experiment 
1, and a 10-fold  excess was added in experiment 2. ND, not done. 
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Fla.  2.  Inhibition of IgG~ monomer binding by monomers. P388 uptake of l~5I-(IgG~a)l was 
inhibited by varying amounts of (IgG2a)l (Q--O) and (IgG2b)l (O--©). Subclass specificity of 
inhibition was noted. 
IgG2a specificity of inhibition was shown for (IgG2a)] binding, whereas aggre- 
gated IgG binding was preferentially inhibited by (IgG2b)l. 
Next, the capacity of IgG aggregates to inhibit the binding of IgG2a monomer 
was measured. These data, shown in Fig. 3, indicate that aggregates of  the IgG2a 
subclass were efficient inhibitors of monomer  IgG2a binding, whereas IgG~ and 
IgG2b aggregates inhibited very poorly. The studies showing absence of inhibi- 
tion with the (IgG2b)4 and (IgG1)4 preparations were performed over a concentra- 
tion range that in previous experiments demonstrated equivalent binding to 
P388 cells of 125I-(IgG2a)4,  125I-(IgG2b)4,  and ~25I-(IgG])4. With these quantities of 
protein (0.5-2.5  ~g) saturation of binding sites was obtained and indicated that 
P388 cells were capable of binding approximately 0.15/~g (IgG)4/106 cells. These 
inhibition data indicate another difference between the binding of IgG aggre- 
gates and monomer to P388 cells. Whereas aggregate binding was inhibited in a 
similar fashion by all aggregates, (IgG2a)l binding was inhibited to a significant 
degree only by aggregated IgG2~. The inhibition studies detailed above strongly 
suggest the presence of two distinct receptors for IgG on P388 cells, one reactive 
with both monomer and aggregated IgG2a, and another receptor reactive with 
aggregates of all three subclasses as well as with monomer IgG2b. 1322  SPECIFICITY  OF  RECEPTORS  FOR  IgG 
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FIG.  3.  Inhibition of IgG2a  monomer binding by various aggregates.  P388 uptake of 125I- 
(IgG~a)~ was inhibited by varying amounts of (IgG2~)4 (0---0),  (IgG~)4 ([J--D), and (IgG2b)4 
(©--©).  IgG2~ monomer binding was inhibited most efficiently by the homologous aggre- 
gate. 
(C)  INHIBITION  OF BINDING OF MONOMERIC  IgG2b TO  P388 CELLS.  The possible 
binding of monomer IgG2b to the same site to which the aggregated proteins 
bound was further investigated by studying the specificity of inhibition of the 
binding of radiolabeled IgG~b monomer. First,  when monomeric proteins were 
used to inhibit the uptake of (IgG2b)l, it was found that at 10-fold molar excess, 
unlabeled IgG2b inhibited the binding of labeled IgG2b by 60%,  whereas IgG2a 
proteins inhibited the binding by only 25%, and IgG3 and IgG1 proteins did not 
inhibit at all. The ability of IgG2a and IgG2b proteins to inhibit the binding of 
IgG2b monomer was further studied in the experiment shown in  Fig.  4.  The 
uptake  of monomer IgG~b was  selectively inhibited  by  (IgG2b)~ compared to 
(IgG2a)l proteins and contrasts markedly with the selective inhibition by (IgG2a)~ 
of monomer IgG2a binding shown in  Fig.  3.  This  indicates that  (IgG2a)l and 
(IgG2b)l bind to different structures on the cell surface. 
Next, the capacity of aggregated proteins to inhibit the uptake of monomer 
IgG2b was examined. The results of these experiments indicated that IgG2a and 
IgG~ aggregates inhibited the uptake of monomer IgG2b as efficiently as aggre- 
gated IgG2b. 50% inhibition was obtained with 0.7-1.7  ~g protein.  These data 
further strengthen the data presented above that suggest that the site to which 
monomer IgG2b binds is most likely the same site to which aggregated proteins 
bind. 
III.  Trypsin  Sensitivity  of Receptors for IgG.  Because of previously pub- 
lished data (12-16),  it was considered likely that the two IgG receptors charac- 
terized in section II might also be distinguishable from one another on the basis 
of differences in sensitivity to tryptic digestion. To analyze this, P388 cells were 
treated with trypsin and subsequently tested for their capacity to bind monomer 
IgG2a or aggregated IgG~b. The results of two experiments are shown in Table 
IV.  Whereas the uptake of (IgG2b)4 was  not inhibited  (and was  actually en- 
hanced significantly), the uptake of (IgG2a)~ was markedly inhibited (61-81%) 
under the conditions used. Although alternative explanations are possible, the C.  H.  HEUSSER,  C.  L.  ANDERSON,  AND  H.  M.  GREY 
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Fro.  4.  Inhibition of IgG2b monomer binding by monomers. P388 uptake of 1251-(IgG2b), was 
inhibited by various amounts of (IgG2b)l  (©--O) and (IgG2a)l  (e--eL  Significant homolo- 
gous specificity of inhibition was noted. 
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TABLE  IV 
Effect of Trypsinization ofP388 Cells on Their Capacity to Bind IgG 
Experiment  Trypsin treatment* 
Percent binding of IgG 
(IgG2b)4  (IgG2a)l 
-  44  4.6 
1  +  49  1.8 
-  53  3.1  2 
+  63  0.6 
* P388 cells (107/ml) were treated with 0.3 mg/ml trypsin for 20 min at 37°C. 
results  are  consistent with the  concept of two distinct  receptors for IgG,  one 
relatively resistant to trypsinization  and the other relatively sensitve. 
Discussion 
The present study on the subclass specificity of receptors for IgG on different 
cell  types  was  undertaken  for  two  reasons:  (a)  the  accumulating  data  that 
immunoglobulins of different subclasses have markedly different biologic activ- 
ity which may be related to their differential  capacities to interact  with cell- 
bound receptors; and (b) to attempt to clarify some of the conflicting reports on 
the subclass specificities of Fc receptors. With respect to the latter point, several 
technical reasons may be responsible for these discrepancies. First, in several of 
the test systems, an EA-rosette assay and its inhibition  by myeloma proteins 
was used. The subclass of the antibody present in the anti-erythrocyte antise- 
rum was not, in general, characterized, and therefore different laboratories may 
have been utilizing antibodies of different subclasses. The pattern of inhibition 
observed with myeloma proteins may have reflected to some extent the subclass 
of the anti-erythrocyte antibody, especially if multiple Fc receptors with differ- 
ent subclass specificity exist. Second, there has been great variation in the form 
of the myeloma proteins used to inhibit the assay systems. In some cases the 1324  SPECIFICITY  OF  RECEPTORS  FOR  IgG 
myelomas were unaggregated, although the presence of small amounts of aggre- 
gates was not specifically tested for.  In other systems the myeloma proteins 
were heat aggregated but no rigorous analysis of the degree of aggregation was 
performed. As shown in Table I, degree of aggregation is an important factor in 
determining the binding capabilities of the myeloma proteins and may well be 
responsible, in part, for the conflicts noted in the literature. 
To avoid the problems stated above,  in the present study we have utilized 
well-defined sizes of chemically aggregated myeloma proteins and have mea- 
sured the direct binding and the inhibition of binding of these proteins onto 
various  IgG  receptor-bearing cells.  Although the  choice of BDB-aggregated 
myeloma proteins  eliminates some of the technical problems present  in  the 
studies mentioned above (viz., the use of antibody of undefined subclass as a 
test system and the use of myeloma proteins with undefined degrees of aggre- 
gation) there are also certain possible disadvantages to the use of BDB-aggre- 
gated myeloma proteins. First, although there is no data to support the possibil- 
ity, the capacity of IgG to interact with an Fc receptor may be altered as a result 
of the conjugation of gamma globulin with BDB. Second, since the aggregation 
induced by BDB occurs via Fc as well as Fab fragments, the orientation of IgG 
within aggregates is not likely to be the same as that which occurs in immune 
complexes.  Despite  these  theoretical  considerations,  BDB  aggregates  have 
proven to be very useful in the study of the biologic functions of immunoglobu- 
lins (4). 
When aggregates of the same molecular size were compared for their capacity 
to bind to different cell types, three patterns of reactivity were demonstrated 
(Table  II).  One  group,  which consisted  of macrophage cell  lines,  bound  all 
subclasses in a similar fashion. Another group bound IgG, and IgG~b proteins to 
a  similar degree but bound IgG2a proteins to a  lesser extent. A third group of 
cells bound IgG1 preferentially to either IgG~a or IgG2b proteins.  It is possible 
that this pattern of reactivity may be simpler than that described, in that the 
difference in the capacity to bind IgG2a proteins between the macrophage cell 
lines and the second group of cells represented by D2N and $49 may be due to 
the  presence of two  Fc  receptor sites  on  macrophages:  one  receptor that  is 
similar in its pattern of specificity to that present on $49 and D2N cells (i.e., 
IgG1 = IgG2b >  IgG2a); and a second receptor that specifically reacts with mono- 
meric and  aggregated IgG~a. The  net result  of these two receptor activities 
would give the observed pattern of aggregated IgG uptake by macrophages (i.e., 
IgG1  =  IgG2b =  IgG2a). 
The possibility that there are two distinct types of Fc receptors on macro- 
phages initially was evaluated because of the subclass specificity observed when 
monomer and aggregated proteins were compared; that is,  monomer uptake 
indicated  IgG2a specificity,  whereas  aggregate  uptake  did  not  suggest  any 
subclass  specificity.  The  evidence  obtained,  both  by  enzymatic degradation 
studies as well as by specificity of inhibition, strongly supports the hypothesis 
that two distinct receptors for IgG are present on the surface ofmacrophages and 
macrophage-like  cell  lines.  Trypsinization  studies  demonstrated that  under 
conditions that led to strong inhibition of the binding of monomeric IgG2a to the 
surface of cells, there was no significant effect on the uptake of radiolabeled C.  H.  HEUSSER,  C.  L.  ANDERSON,  AND  H.  M.  GREY  1325 
aggregates by these same cells. The inhibition of the binding of monomer IgG2a 
by trypsin treatment of cells is in keeping with the studies of Unkeless and 
Eisen on P388 cells, (14) but conflicts with the data of Walker on another macro- 
phage-like cell line, IC-21  (17). Whether this conflict is due to the different cell 
lines  used  or  to  technical  differences in  the trypsinization  procedure is  not 
known. 
Inhibition studies gave independent evidence for the presence of two receptors 
on macrophages. The most striking differences in inhibition patterns between 
monomer IgG2a binding  and  aggregate  IgG binding  which support  the two- 
receptor hypothesis are: (a) when inhibition of binding of monomer and aggre- 
gates  was  investigated  utilizing  monomeric proteins  as  inhibitors,  (IgG2a)l 
binding  was  preferentially inhibited  by  (IgGla)~,  whereas the binding  of all 
subclasses  of aggregates  was  preferentially inhibited  by  (IgG2b)~; (b)  when 
inhibition by aggregates was investigated, the binding of (IgG2a)l was preferen- 
tially inhibited by aggregated IgG2~, whereas the binding of aggregated proteins 
was  equally  inhibitable  by  IgG1,  IgG2a,  or  IgG2b aggregates.  The  observed 
heterogeneity of  binding was not due to different populations of cells in the P388 
cultures  bearing  single  receptors with  different specificities  since  autoradi- 
ograms demonstrated that  aggregated IgG  (of all  subclasses)  and  monomer 
IgG2a each bound to greater than 95% of the P388 cells. 
It was also shown in this study that (IgG2b)l proteins were bound to P388 cells 
at a site distinct from the (IgG~)~ site since the uptake of (IgG2b)l protein could 
be inhibited preferentially by  (IgG2b)~ and not by  (IgG~a)~ in  contrast to the 
preferential inhibition of (IgG2a)~ binding by (IgG2a)~. Because of the capacity of 
(IgG2b)~ to inhibit the binding of all aggregates, it is considered most likely that 
monomer IgG~b binds to  the surface of P388  cells at the same site to  which 
aggregates bind. 
Our results confirm and extend previous studies by Unkeless and Eisen on the 
binding of monomeric proteins to macrophages (14). These authors have shown 
preferential binding of monomer IgG2~ proteins to membrane receptors which 
are trypsin sensitive. Askenase and Hayden also have presented evidence for 
trypsin-sensitive  sites  on  mouse  macrophages  which bind  oxazolone-specific 
cytophilic antibody of the IgG2~ subclass  (15). In a  recent report, Walker de- 
scribed  IgG  binding  and  inhibition  studies  similar  to  ours  using  an  SV-40 
transformed macrophage line, IC-21  (17). Although his basic conclusion of the 
presence  of two  distinct  receptors  is  in  accord  with  our  appraisal,  certain 
differences exist in the pattern of reactivity obtained with IC-21  and the data 
presented in our study. Walker observed significant binding only with (IgG2~)~ 
and aggregated IgG2a and IgG2b, whereas we found equivalent binding of all 
aggregated IgG subclasses  as well as significant binding of (IgG2b)~. Further 
evidence for dual Fc receptors on mouse macrophages is found in the work of 
Kossard and Nelson (16) who noted that anti-erythrocyte cytophilic antibody in 
mouse serum taken soon after sensitization binds to trypsin-sensitive sites on 
macrophages, whereas antibody obtained long after primary sensitization binds 
to trypsin-resistant sites. 
Although it is difficult to explain the data that we have presented in this 
study  by  postulating  a  mechanism other  than  there  being  two  distinct  Fc 1326  SPECIFICITY  OF  RECEPTORS  FOR  IgG 
receptors on P388  cells,  it is to be  stressed that the evidence to support this 
concept is basically indirect and proof of the existence of two receptors must 
await their biochemical isolation and characterization. 
Summary 
To  evaluate  subclass  specificity and  aggregate  size  requirements  of IgG 
receptors on mouse cells, we measured binding of radiolabeled monomeric and 
BDB-aggregated mouse  myeloma proteins fractionated into various sizes by 
means of gel filtration. Monomers, tetramers, and high molecular weight (-107 
daltons) aggregates were used. The various cells and cell lines studied could be 
segregated into three patterns of reactivity: (a) Macrophage and macrophage- 
like cell lines bound monomer IgG2a preferentially; high molecular weight IgG 
aggregates bound as follows: IgG1 = IgG2b = IgG2a. (b) Lymphoid lines D2N and 
$49 showed no capacity to bind monomer IgG2a; high molecular weight aggre- 
gates bound as follows: IgG1 = IgG2b >  IgG2~. (c) Other Thy-l-positive lymphoid 
cell lines (EL4 and L5178) and normal T and B cells showed no capacity to bind 
monomer IgG; high molecular weight IgG aggregates bound to a  lesser extent 
than to cells of the first two categories in the following manner: IgG~ >  IgG2b -> 
IgG2a. 
The  variable  pattern  of reactivity of the  macrophage-like  cell  lines  with 
monomer and aggregated IgG suggested that two distinct receptors for IgG were 
present: one capable of binding IgG2a and another capable of binding all aggre- 
gates.  Further evidence for this  hypothesis was  obtained by analysis of the 
inhibitory capacity of different IgG subclasses on the binding of aggregated IgG 
and monomer IgG2a to  P388  cells.  Inhibition of monomer IgG2~ binding was 
effected only by monomer or aggregated IgG2a, whereas inhibition of binding of 
aggregated IgG1 or IgG2b was noted with aggregates of all three subclasses with 
some preferential inhibition by monomer IgG2b being observed.  Furthermore, 
monomer IgG2b binding was preferentially inhibitable by monomer IgG2b. It is 
postulated from these data that two receptor sites are present on this macro- 
phage-like cell line, one reactive with aggregates of all three subclasses as well 
as monomer IgG2b, and another receptor specific for monomer IgG2a which also 
binds aggregated IgG2a. Support of this concept was obtained by trypsinization 
experiments in which the binding of monomer IgG2a was markedly decreased by 
trypsin treatment of cells, whereas the binding of aggregated IgG2b was unaf- 
fected by this treatment. 
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